A two-decade experience of head and neck paragangliomas in a whole population-based single centre cohort

Eur Arch Otorhinolaryngol. 2015 Aug;272(8):2045-53. doi: 10.1007/s00405-014-3161-9. Epub 2014 Jun 29.

Abstract

Paragangliomas are rare neuroendocrine tumours arising from neural crest-derived tissue. In the head and neck region typical locations are the carotid bifurcation, vagal nerve or jugulotympanic region. Paragangliomas are normally benign, and malignant transformation is rare. During the past decade the understanding of the genetic and molecular aetiology has had an important clinical impact on the management of PGs. This is a retrospective review of all histologically verified paragangliomas diagnosed and managed at an academic tertiary care referral centre between 1990 and 2010. Data on age, sex, symptoms, tumour location, management and follow-up were recorded. There were 64 patients with 74 tumours. Thirty-six per cent of the tumours were located in the carotid body region, 48 % in the jugulotympanic region and 15 % in the vagal nerve. One tumour was located in the dorsal neck. Most (95 %) of the patients were treated primarily with surgery and with curative intent. Definitive radiation therapy was primarily given to two patients. Recurrent or residual tumours were treated with surgery in three patients and with radiation therapy in nine patients. The typical long-term post-operative sequel was vocal cord paralysis. Local recurrence was found in 6 % of patients. Symptoms and findings related to paragangliomas are variable and management should be individualized. Surgery remains the primary choice of the current treatment options, but often is challenging and warrants a multidisciplinary approach. We present an algorithm on the management of head and neck paragangliomas based on current knowledge.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Female
  • Finland / epidemiology
  • Head and Neck Neoplasms* / diagnosis
  • Head and Neck Neoplasms* / epidemiology
  • Head and Neck Neoplasms* / genetics
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Male
  • Middle Aged
  • Mitochondrial Proteins / genetics
  • Neoplasm Recurrence, Local
  • Outcome Assessment, Health Care
  • Paraganglioma* / epidemiology
  • Paraganglioma* / genetics
  • Paraganglioma* / pathology
  • Paraganglioma* / therapy
  • Postoperative Complications / epidemiology*
  • Radiotherapy* / methods
  • Radiotherapy* / statistics & numerical data
  • Retrospective Studies
  • Succinate Dehydrogenase / genetics*
  • Surgical Procedures, Operative* / methods
  • Surgical Procedures, Operative* / statistics & numerical data
  • Vocal Cord Paralysis* / epidemiology
  • Vocal Cord Paralysis* / etiology

Substances

  • Mitochondrial Proteins
  • SDHAF2 protein, human
  • SDHD protein, human
  • SDHB protein, human
  • Succinate Dehydrogenase